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Introduction
Increased regulatory T cell (Treg) numbers within tumors
and circulation of cancer patients, observed in early stu-
dies, implied their involvement in pathogenesis and dis-
ease progression. Also, Treg increase in cancer patients
have been associated with reduced survival and inhibition
of anti-tumor immune responses. Therefore, decreasing
the numbers and/or function of Tregs is needed to facili-
tate better outcomes for cancer patients. The phosphoino-
sitide 3-kinase (PI3K-Akt) pathway plays important roles
in cell growth, survival, and proliferation of T cells. How-
ever, little is known about the role of different isoforms of
PI3K in different T subsets activation. Here, we explore
the role of PI3K isoforms in Tregs and conventional T cell
activation with the intention of identifying potential differ-
ences to selectively inhibit Tregs.
Methods
For in vitro analysis, FACS-sorted Tregs and Tconvs from
Foxp3-GFP mice were stimulated (anti-CD3 Ab/anti-CD28
Ab/IL-2) with or without inhibitors for 72 hrs. Phosphory-
lation of Akt (S473) and S6 was analyzed by flow. Violet
Cell Trace (VCT) proliferation assay was performed using
flow cytometry. The in vivo effect of inhibitors on fre-
quency of different T cell subsets were assessed in TC-1
tumor-bearing mice on days 3 and 6 after treatment.
Results
We found that pharmacologic inhibition of PI3Kδ isoform
but not PI3Ka or PI3Kb exhibit a selective blockade of
PI3K/Akt signaling and the inhibition of proliferation of
Tregs. In contrast, the inhibition of each individual Class
IA PI3K isoform in conventional T cells did not affect their
activation and proliferation. Further, our data on combined
inhibition of PI3K isoforms suggest that these isoforms
are redundant and compensate for each other in Tconvs.
Interestingly, PI3Ka or PI3Kb were unable to compensate
for PI3Kδ in Tregs, making PI3Kδ inhibition a selective
Treg-targeting approach. Importantly, we also show that
inhibition of PI3Kδ and not PI3Ka PI3Kb in tumor-bearing
mice significantly decreases the level of Tregs without
affecting other T cell subsets. We believe that our findings
provide a basis for development of novel cancer immu-
notherapies based on selective inhibition of Tregs.
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